Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer
NCT ID: NCT05690399
Last Updated: 2023-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2023-01-31
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer
NCT05123391
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
NCT00002889
Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate Cancer
NCT04835454
Radiation and Androgen Ablation for Prostate Cancer
NCT01517451
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population
NCT05343936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Male patient , Age ≥ 40 yo
* Diagnosed as prostate cancer from ( 2013- 2023 ) proved by biopsy in South Egypt Cancer Institute "SECI" \& Asyut clinical oncology department
* Newly diagnosed/ metastatic at presentation
* ECOG 0-4
• Exclusion criteria:
* Having Other types of malignancy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiotherapy
Effect of radiotherapy on patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed as prostate cancer from ( 2013- 2023 ) proved by biopsy
* Newly diagnosed/ metastatic at presentation
* ECOG 0-4
Exclusion Criteria
40 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aml Mohamed Haridy
Evaluation of clinical and pathological characteristics and routine treatment of patients with prostate cancer in 2 centers in Asyut
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Assiut University
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Cancer Stat Facts: Prostate Cancer \[Internet\]. SEER, 2018.
M Alizadeh, S Alizadeh, Glob J Health Sci, 6: 2014. Survey of clinical and pathological characteristics and outcomes of patients with prostate cancer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Prostate cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.